Big Gain For AcelRx Pharmaceuticals, Inc.
Wed, Jul 14, 2021 at 05:33 PM
AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ) rocketted at $1.51, representing a gain of 23.8%. On Tue, Jul 13, 2021, ACRX:NASDAQ hit a New 2-Week Low of $1.22. The stock got featured on our News Catalysts scanner on Wed, Jul 14, 2021 at 01:27 PM in the 'INVESTOR UPDATE' category. From Tue, Jun 29, 2021, the stock recorded 11.11% Up Days and 10.00% Green Days
The stock spiked on Tue, Jun 08, 2021 at $1.67 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ)
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of therapies for the treatment of acute pain.
Top 10 Gainers:
- SGOCO Group, Ltd. (SGOC:NASDAQ), 37.64%
- BON (BON:NASDAQ), 33.6%
- VRPX (VRPX:NASDAQ), 30.62%
- Wilhelmina International, Inc. (WHLM:NASDAQ), 24.7%
- AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ), 23.77%
- Kura Sushi USA, Inc. (KRUS:NASDAQ), 23.15%
- CorePoint Lodging Inc. (CPLG:NYSE), 21.83%
- U.S. Energy Corp. (USEG:NASDAQ), 21.15%
- GBS (GBS:NASDAQ), 16.89%
- Westwood Holdings Group, Inc. (WHG:NYSE), 15.95%